China Pharma Holdings Statistics
Total Valuation
CPHI has a market cap or net worth of $44.98 million. The enterprise value is $48.67 million.
| Market Cap | 44.98M |
| Enterprise Value | 48.67M |
Important Dates
The next estimated earnings date is Friday, August 14, 2026, after market close.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CPHI has 40.52 million shares outstanding. The number of shares has increased by 343.17% in one year.
| Current Share Class | 40.52M |
| Shares Outstanding | 40.52M |
| Shares Change (YoY) | +343.17% |
| Shares Change (QoQ) | +278.67% |
| Owned by Insiders (%) | 98.02% |
| Owned by Institutions (%) | 0.06% |
| Float | 800,615 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 11.27 |
| Forward PS | n/a |
| PB Ratio | 1.21 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 271.54 |
| P/OCF Ratio | 269.91 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 12.19 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 293.80 |
Financial Position
The company has a current ratio of 0.28, with a Debt / Equity ratio of 0.10.
| Current Ratio | 0.28 |
| Quick Ratio | 0.06 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | 23.28 |
| Interest Coverage | -35.96 |
Financial Efficiency
Return on equity (ROE) is -16.12% and return on invested capital (ROIC) is -8.39%.
| Return on Equity (ROE) | -16.12% |
| Return on Assets (ROA) | -7.26% |
| Return on Invested Capital (ROIC) | -8.39% |
| Return on Capital Employed (ROCE) | -9.50% |
| Weighted Average Cost of Capital (WACC) | 9.88% |
| Revenue Per Employee | $18,565 |
| Profits Per Employee | -$16,489 |
| Employee Count | 215 |
| Asset Turnover | 0.13 |
| Inventory Turnover | 2.12 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -35.47% in the last 52 weeks. The beta is 1.15, so CPHI's price volatility has been higher than the market average.
| Beta (5Y) | 1.15 |
| 52-Week Price Change | -35.47% |
| 50-Day Moving Average | 1.01 |
| 200-Day Moving Average | 1.06 |
| Relative Strength Index (RSI) | 48.71 |
| Average Volume (20 Days) | 11,198,833 |
Short Selling Information
The latest short interest is 413,843, so 1.02% of the outstanding shares have been sold short.
| Short Interest | 413,843 |
| Short Previous Month | 32,783 |
| Short % of Shares Out | 1.02% |
| Short % of Float | 51.69% |
| Short Ratio (days to cover) | 0.07 |
Income Statement
In the last 12 months, CPHI had revenue of $3.99 million and -$3.55 million in losses. Loss per share was -$0.36.
| Revenue | 3.99M |
| Gross Profit | 289,598 |
| Operating Income | -3.45M |
| Pretax Income | -3.55M |
| Net Income | -3.55M |
| EBITDA | -1.44M |
| EBIT | -3.60M |
| Loss Per Share | -$0.36 |
Balance Sheet
The company has $168,474 in cash and $3.86 million in debt, with a net cash position of -$3.69 million or -$0.09 per share.
| Cash & Cash Equivalents | 168,474 |
| Total Debt | 3.86M |
| Net Cash | -3.69M |
| Net Cash Per Share | -$0.09 |
| Equity (Book Value) | 37.02M |
| Book Value Per Share | 0.91 |
| Working Capital | -5.26M |
Cash Flow
In the last 12 months, operating cash flow was $166,645 and capital expenditures -$1,000, giving a free cash flow of $165,645.
| Operating Cash Flow | 166,645 |
| Capital Expenditures | -1,000 |
| Depreciation & Amortization | 2.15M |
| Net Borrowing | -296,532 |
| Free Cash Flow | 165,645 |
| FCF Per Share | $0.00 |
Margins
Gross margin is 7.26%, with operating and profit margins of -86.34% and -88.82%.
| Gross Margin | 7.26% |
| Operating Margin | -86.34% |
| Pretax Margin | -88.82% |
| Profit Margin | -88.82% |
| EBITDA Margin | -36.15% |
| EBIT Margin | -90.13% |
| FCF Margin | 4.15% |
Dividends & Yields
CPHI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -343.17% |
| Shareholder Yield | -343.17% |
| Earnings Yield | -7.88% |
| FCF Yield | 0.37% |
Analyst Forecast
The average price target for CPHI is $2,250.00, which is 202,602.70% higher than the current price. The consensus rating is "Buy".
| Price Target | $2,250.00 |
| Price Target Difference | 202,602.70% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 15, 2025. It was a reverse split with a ratio of 1:10.
| Last Split Date | Apr 15, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
CPHI has an Altman Z-Score of -1.38 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.38 |
| Piotroski F-Score | 3 |